ImmunityBio Securities Lawsuit Targets Anktiva Claims; Investors Eye May 26 Deadline
ImmunityBio faces securities class action over alleged false Anktiva statements. Shareholders have until May 26, 2026 to register claims.
IBRXinvestor lossesshareholder lawsuit